Invictus Therapeutics
PrivateLast Round
Grant
Jan 12, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Invictus Therapeutics is a biotechnology company developing next-generation insulin analogs engineered for automated insulin delivery systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Invictus Therapeutics Comparables
Compare Invictus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Metabulin | 84% | |
| Arecor Therapeutics PLC | 75% | |
| Halozyme Therapeutics | 74% |
Invictus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 12, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
Received grant funding to support operations.
Invictus Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Invictus Therapeutics's valuation, stock price, and market status.
Is Invictus Therapeutics a public or private company?
Invictus Therapeutics is a private company.
What is the current stock price of Invictus Therapeutics?
Invictus Therapeutics is a private company with no public stock price. Caplight tracks Invictus Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Invictus Therapeutics worth (valuation)?
Valuation information for Invictus Therapeutics is not publicly available.
Can I buy Invictus Therapeutics stock?
Invictus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Invictus Therapeutics's last funding round?
Invictus Therapeutics's most recent funding round was Grant on January 12, 2026.
Who are the main investors in Invictus Therapeutics?
Investor information for Invictus Therapeutics is not publicly disclosed.
Will Invictus Therapeutics IPO soon?
No public IPO plans have been announced for Invictus Therapeutics.
How can I track Invictus Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Invictus Therapeutics's secondary market activity and sign up for updates.